Advise the patient to read the FDA-approved patient labeling (Medication Guide).
Hepatotoxicity
Inform patients of the signs and symptoms of hepatotoxicity. Advise patients to contact their healthcare provider immediately for signs or symptoms of hepatotoxicity [see Warnings and Precautions (5.1)].
Cardiovascular Events
Advise patients to contact their healthcare provider if they develop symptoms of heart failure [see Warnings and Precautions (5.2)].
QT Prolongation and Torsade de Pointes
Inform patients of the signs and symptoms of QT prolongation. Advise patients to contact their healthcare provider immediately in the event of syncope, pre-syncopal symptoms, and cardiac palpitations [see Warnings and Precautions (5.3)].
Hypertension
Inform patients of the signs and symptoms of hypertension. Advise patients to undergo routine blood pressure monitoring and to contact their health care provider if blood pressure is elevated or if they experience signs or symptoms of hypertension [see Warnings and Precautions (5.4)].
Hemorrhagic Events
Advise patients that SUTENT can cause severe bleeding. Advise patients to immediately contact their healthcare provider for bleeding or symptoms of bleeding [see Warnings and Precautions (5.5)].
Gastrointestinal Disorders
Advise patients that gastrointestinal disorders such as diarrhea, nausea, vomiting, and constipation may develop during SUTENT treatment and to seek immediate medical attention if they experience persistent or severe abdominal pain because cases of gastrointestinal perforation and fistula have been reported in patients taking SUTENT [see Warnings and Precautions (5.5), Adverse Reactions (6.1)].
Dermatologic Effects and Toxicities
Advise patients that depigmentation of the hair or skin may occur during treatment with SUTENT due to the drug color (yellow). Other possible dermatologic effects may include dryness, thickness or cracking of skin, blister or rash on the palms of the hands and soles of the feet. Severe dermatologic toxicities including Stevens-Johnson syndrome, Toxic Epidermal Necrolysis, erythema multiforme, and necrotizing fasciitis have been reported. Advise patients to immediately inform their healthcare provider if severe dermatologic reactions occur [see Warnings and Precautions (5.9), Adverse Reactions (6.1)].
Reversible Posterior Leukoencephalopathy Syndrome
Inform patients of the signs and symptoms of reversible posterior leukoencephalopathy syndrome. Advise patients to contact their healthcare provider if they develop symptoms of reversible posterior leukoencephalopathy syndrome [see Warnings and Precautions (5.10)].
Thyroid Dysfunction
Advise patients that SUTENT can cause thyroid dysfunction. Advise patient to contact their healthcare provider if symptoms of abnormal thyroid function occur [see Warnings and Precautions (5.11)].
Hypoglycemia
Advise patients that SUTENT can cause severe hypoglycemia and may be more severe in patients with diabetes taking antidiabetic medications. Inform patients of the signs, symptoms, and risks associated with hypoglycemia. Advise patients to immediately inform their healthcare provider if severe signs or symptoms of hypoglycemia occur [see Warnings and Precautions (5.12)].
Osteonecrosis of the Jaw
Advise patients regarding good oral hygiene practices and to inform their healthcare provider of any planned dental procedures. Advise patients to immediately contact their healthcare provider for signs or symptoms associated with osteonecrosis of the jaw [see Warnings and Precautions (5.13)].
Impaired Wound Healing
Advise patients that SUTENT impairs wound healing. Advise patients to inform their healthcare provider of any planned surgical procedures [see Warnings and Precautions (5.14)].
Concomitant Medications
Advise patients to inform their healthcare providers of all concomitant medications, including over-the-counter medications and dietary supplements [see Drug Interactions (7)].
Embryo-Fetal Toxicity
Advise pregnant women of the potential risk to a fetus. Advise females of reproductive potential to inform their healthcare provider of a known or suspected pregnancy [see Warnings and Precautions (5.15), Use in Specific Populations (8.1)].
Advise females of reproductive potential to use effective contraception during treatment and for 4 weeks after receiving the last dose of SUTENT [see Use in Specific Populations (8.3)].
Advise males with female partners of reproductive potential to use effective contraception during treatment and for 7 weeks after receiving the last dose of SUTENT [see Use in Specific Populations (8.3)].
Lactation
Advise women not to breastfeed during treatment with SUTENT and for at least 4 weeks after the last dose [see Use in Specific Populations (8.2)].
Infertility
Advise patients that SUTENT may impair male and female fertility [see Use in Specific Populations (8.3), Nonclinical Toxicology (13.1)].
This Medication Guide has been approved by the U.S. Food and Drug Administration. | Revised: August 2021 | ||
MEDICATION GUIDE SUTENT (su TENT) (sunitinib malate) capsules | |||
What is the most important information I should know about SUTENT? SUTENT can cause serious side effects including:
See "What are the possible side effects of SUTENT?" for more information about side effects. | |||
What is SUTENT? SUTENT is a prescription medicine used to treat:
| |||
Before taking SUTENT tell your healthcare provider about all of your medical conditions, including if you:
Tell your healthcare provider about all the medicines you take, including prescription medicines and over-the-counter medicines, vitamins, and herbal supplements. Using SUTENT with certain other medicines can cause serious side effects. You may have an increased risk of severe jawbone problems (osteonecrosis) if you take SUTENT and a bisphosphonate medicine. Especially tell your healthcare provider if you are taking or have taken an osteoporosis medicine. Know the medicines you take. Keep a list of them to show your healthcare provider and pharmacist when you get a new medicine. | |||
How should I take SUTENT?
| |||
What are possible side effects of SUTENT? SUTENT may cause serious side effects, including:
| |||
|
| ||
| |||
|
| ||
Your healthcare provider may prescribe medicine for you to treat high blood pressure, if needed. | |||
| |||
|
| ||
| |||
|
| ||
| |||
|
| ||
Common side effects of SUTENT include: | |||
|
| ||
The medicine in SUTENT is yellow, and it may make your skin look yellow. Your skin and hair may get lighter in color. SUTENT may also cause other skin problems including: dryness, thickness or cracking of the skin. These are not all of the possible side effects of SUTENT. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. | |||
How do I store SUTENT?
| |||
General information about the safe and effective use of SUTENT. Medicines are sometimes prescribed for purposes other than those listed in a Medication Guide. Do not use SUTENT for a condition for which it was not prescribed. Do not give SUTENT to other people, even if they have the same symptoms that you have. It may harm them. You can ask your healthcare provider or pharmacist for information about SUTENT that is written for health professionals. | |||
What are the ingredients in SUTENT? Active ingredient: sunitinib malate Inactive ingredients: mannitol, croscarmellose sodium, povidone (K-25), and magnesium stearate. Orange gelatin capsule shells: titanium dioxide, and red iron oxide. Caramel gelatin capsule shells: titanium dioxide, red iron oxide, yellow iron oxide, and black iron oxide. Yellow gelatin capsule shells: titanium dioxide and yellow iron oxide. White printing ink: shellac, propylene glycol, sodium hydroxide, povidone, and titanium dioxide. Black printing ink: shellac, propylene glycol, potassium hydroxide and black iron oxide. LAB-0361-12.0 For more information go to www.SUTENT.com or call 1-877-5-SUTENT. |
Advise the patient to read the FDA-approved patient labeling (Medication Guide).
Hepatotoxicity
Inform patients of the signs and symptoms of hepatotoxicity. Advise patients to contact their healthcare provider immediately for signs or symptoms of hepatotoxicity [see Warnings and Precautions (5.1)].
Cardiovascular Events
Advise patients to contact their healthcare provider if they develop symptoms of heart failure [see Warnings and Precautions (5.2)].
QT Prolongation and Torsade de Pointes
Inform patients of the signs and symptoms of QT prolongation. Advise patients to contact their healthcare provider immediately in the event of syncope, pre-syncopal symptoms, and cardiac palpitations [see Warnings and Precautions (5.3)].
Hypertension
Inform patients of the signs and symptoms of hypertension. Advise patients to undergo routine blood pressure monitoring and to contact their health care provider if blood pressure is elevated or if they experience signs or symptoms of hypertension [see Warnings and Precautions (5.4)].
Hemorrhagic Events
Advise patients that SUTENT can cause severe bleeding. Advise patients to immediately contact their healthcare provider for bleeding or symptoms of bleeding [see Warnings and Precautions (5.5)].
Gastrointestinal Disorders
Advise patients that gastrointestinal disorders such as diarrhea, nausea, vomiting, and constipation may develop during SUTENT treatment and to seek immediate medical attention if they experience persistent or severe abdominal pain because cases of gastrointestinal perforation and fistula have been reported in patients taking SUTENT [see Warnings and Precautions (5.5), Adverse Reactions (6.1)].
Dermatologic Effects and Toxicities
Advise patients that depigmentation of the hair or skin may occur during treatment with SUTENT due to the drug color (yellow). Other possible dermatologic effects may include dryness, thickness or cracking of skin, blister or rash on the palms of the hands and soles of the feet. Severe dermatologic toxicities including Stevens-Johnson syndrome, Toxic Epidermal Necrolysis, erythema multiforme, and necrotizing fasciitis have been reported. Advise patients to immediately inform their healthcare provider if severe dermatologic reactions occur [see Warnings and Precautions (5.9), Adverse Reactions (6.1)].
Reversible Posterior Leukoencephalopathy Syndrome
Inform patients of the signs and symptoms of reversible posterior leukoencephalopathy syndrome. Advise patients to contact their healthcare provider if they develop symptoms of reversible posterior leukoencephalopathy syndrome [see Warnings and Precautions (5.10)].
Thyroid Dysfunction
Advise patients that SUTENT can cause thyroid dysfunction. Advise patient to contact their healthcare provider if symptoms of abnormal thyroid function occur [see Warnings and Precautions (5.11)].
Hypoglycemia
Advise patients that SUTENT can cause severe hypoglycemia and may be more severe in patients with diabetes taking antidiabetic medications. Inform patients of the signs, symptoms, and risks associated with hypoglycemia. Advise patients to immediately inform their healthcare provider if severe signs or symptoms of hypoglycemia occur [see Warnings and Precautions (5.12)].
Osteonecrosis of the Jaw
Advise patients regarding good oral hygiene practices and to inform their healthcare provider of any planned dental procedures. Advise patients to immediately contact their healthcare provider for signs or symptoms associated with osteonecrosis of the jaw [see Warnings and Precautions (5.13)].
Impaired Wound Healing
Advise patients that SUTENT impairs wound healing. Advise patients to inform their healthcare provider of any planned surgical procedures [see Warnings and Precautions (5.14)].
Concomitant Medications
Advise patients to inform their healthcare providers of all concomitant medications, including over-the-counter medications and dietary supplements [see Drug Interactions (7)].
Embryo-Fetal Toxicity
Advise pregnant women of the potential risk to a fetus. Advise females of reproductive potential to inform their healthcare provider of a known or suspected pregnancy [see Warnings and Precautions (5.15), Use in Specific Populations (8.1)].
Advise females of reproductive potential to use effective contraception during treatment and for 4 weeks after receiving the last dose of SUTENT [see Use in Specific Populations (8.3)].
Advise males with female partners of reproductive potential to use effective contraception during treatment and for 7 weeks after receiving the last dose of SUTENT [see Use in Specific Populations (8.3)].
Lactation
Advise women not to breastfeed during treatment with SUTENT and for at least 4 weeks after the last dose [see Use in Specific Populations (8.2)].
Infertility
Advise patients that SUTENT may impair male and female fertility [see Use in Specific Populations (8.3), Nonclinical Toxicology (13.1)].
This Medication Guide has been approved by the U.S. Food and Drug Administration. | Revised: August 2021 | ||
MEDICATION GUIDE SUTENT (su TENT) (sunitinib malate) capsules | |||
What is the most important information I should know about SUTENT? SUTENT can cause serious side effects including:
See "What are the possible side effects of SUTENT?" for more information about side effects. | |||
What is SUTENT? SUTENT is a prescription medicine used to treat:
| |||
Before taking SUTENT tell your healthcare provider about all of your medical conditions, including if you:
Tell your healthcare provider about all the medicines you take, including prescription medicines and over-the-counter medicines, vitamins, and herbal supplements. Using SUTENT with certain other medicines can cause serious side effects. You may have an increased risk of severe jawbone problems (osteonecrosis) if you take SUTENT and a bisphosphonate medicine. Especially tell your healthcare provider if you are taking or have taken an osteoporosis medicine. Know the medicines you take. Keep a list of them to show your healthcare provider and pharmacist when you get a new medicine. | |||
How should I take SUTENT?
| |||
What are possible side effects of SUTENT? SUTENT may cause serious side effects, including:
| |||
|
| ||
| |||
|
| ||
Your healthcare provider may prescribe medicine for you to treat high blood pressure, if needed. | |||
| |||
|
| ||
| |||
|
| ||
| |||
|
| ||
Common side effects of SUTENT include: | |||
|
| ||
The medicine in SUTENT is yellow, and it may make your skin look yellow. Your skin and hair may get lighter in color. SUTENT may also cause other skin problems including: dryness, thickness or cracking of the skin. These are not all of the possible side effects of SUTENT. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. | |||
How do I store SUTENT?
| |||
General information about the safe and effective use of SUTENT. Medicines are sometimes prescribed for purposes other than those listed in a Medication Guide. Do not use SUTENT for a condition for which it was not prescribed. Do not give SUTENT to other people, even if they have the same symptoms that you have. It may harm them. You can ask your healthcare provider or pharmacist for information about SUTENT that is written for health professionals. | |||
What are the ingredients in SUTENT? Active ingredient: sunitinib malate Inactive ingredients: mannitol, croscarmellose sodium, povidone (K-25), and magnesium stearate. Orange gelatin capsule shells: titanium dioxide, and red iron oxide. Caramel gelatin capsule shells: titanium dioxide, red iron oxide, yellow iron oxide, and black iron oxide. Yellow gelatin capsule shells: titanium dioxide and yellow iron oxide. White printing ink: shellac, propylene glycol, sodium hydroxide, povidone, and titanium dioxide. Black printing ink: shellac, propylene glycol, potassium hydroxide and black iron oxide. LAB-0361-12.0 For more information go to www.SUTENT.com or call 1-877-5-SUTENT. |
Advise the patient to read the FDA-approved patient labeling (Medication Guide).
Hepatotoxicity
Inform patients of the signs and symptoms of hepatotoxicity. Advise patients to contact their healthcare provider immediately for signs or symptoms of hepatotoxicity [see Warnings and Precautions (5.1)].
Cardiovascular Events
Advise patients to contact their healthcare provider if they develop symptoms of heart failure [see Warnings and Precautions (5.2)].
QT Prolongation and Torsade de Pointes
Inform patients of the signs and symptoms of QT prolongation. Advise patients to contact their healthcare provider immediately in the event of syncope, pre-syncopal symptoms, and cardiac palpitations [see Warnings and Precautions (5.3)].
Hypertension
Inform patients of the signs and symptoms of hypertension. Advise patients to undergo routine blood pressure monitoring and to contact their health care provider if blood pressure is elevated or if they experience signs or symptoms of hypertension [see Warnings and Precautions (5.4)].
Hemorrhagic Events
Advise patients that SUTENT can cause severe bleeding. Advise patients to immediately contact their healthcare provider for bleeding or symptoms of bleeding [see Warnings and Precautions (5.5)].
Gastrointestinal Disorders
Advise patients that gastrointestinal disorders such as diarrhea, nausea, vomiting, and constipation may develop during SUTENT treatment and to seek immediate medical attention if they experience persistent or severe abdominal pain because cases of gastrointestinal perforation and fistula have been reported in patients taking SUTENT [see Warnings and Precautions (5.5), Adverse Reactions (6.1)].
Dermatologic Effects and Toxicities
Advise patients that depigmentation of the hair or skin may occur during treatment with SUTENT due to the drug color (yellow). Other possible dermatologic effects may include dryness, thickness or cracking of skin, blister or rash on the palms of the hands and soles of the feet. Severe dermatologic toxicities including Stevens-Johnson syndrome, Toxic Epidermal Necrolysis, erythema multiforme, and necrotizing fasciitis have been reported. Advise patients to immediately inform their healthcare provider if severe dermatologic reactions occur [see Warnings and Precautions (5.9), Adverse Reactions (6.1)].
Reversible Posterior Leukoencephalopathy Syndrome
Inform patients of the signs and symptoms of reversible posterior leukoencephalopathy syndrome. Advise patients to contact their healthcare provider if they develop symptoms of reversible posterior leukoencephalopathy syndrome [see Warnings and Precautions (5.10)].
Thyroid Dysfunction
Advise patients that SUTENT can cause thyroid dysfunction. Advise patient to contact their healthcare provider if symptoms of abnormal thyroid function occur [see Warnings and Precautions (5.11)].
Hypoglycemia
Advise patients that SUTENT can cause severe hypoglycemia and may be more severe in patients with diabetes taking antidiabetic medications. Inform patients of the signs, symptoms, and risks associated with hypoglycemia. Advise patients to immediately inform their healthcare provider if severe signs or symptoms of hypoglycemia occur [see Warnings and Precautions (5.12)].
Osteonecrosis of the Jaw
Advise patients regarding good oral hygiene practices and to inform their healthcare provider of any planned dental procedures. Advise patients to immediately contact their healthcare provider for signs or symptoms associated with osteonecrosis of the jaw [see Warnings and Precautions (5.13)].
Impaired Wound Healing
Advise patients that SUTENT impairs wound healing. Advise patients to inform their healthcare provider of any planned surgical procedures [see Warnings and Precautions (5.14)].
Concomitant Medications
Advise patients to inform their healthcare providers of all concomitant medications, including over-the-counter medications and dietary supplements [see Drug Interactions (7)].
Embryo-Fetal Toxicity
Advise pregnant women of the potential risk to a fetus. Advise females of reproductive potential to inform their healthcare provider of a known or suspected pregnancy [see Warnings and Precautions (5.15), Use in Specific Populations (8.1)].
Advise females of reproductive potential to use effective contraception during treatment and for 4 weeks after receiving the last dose of SUTENT [see Use in Specific Populations (8.3)].
Advise males with female partners of reproductive potential to use effective contraception during treatment and for 7 weeks after receiving the last dose of SUTENT [see Use in Specific Populations (8.3)].
Lactation
Advise women not to breastfeed during treatment with SUTENT and for at least 4 weeks after the last dose [see Use in Specific Populations (8.2)].
Infertility
Advise patients that SUTENT may impair male and female fertility [see Use in Specific Populations (8.3), Nonclinical Toxicology (13.1)].
This Medication Guide has been approved by the U.S. Food and Drug Administration. | Revised: August 2021 | ||
MEDICATION GUIDE SUTENT (su TENT) (sunitinib malate) capsules | |||
What is the most important information I should know about SUTENT? SUTENT can cause serious side effects including:
See "What are the possible side effects of SUTENT?" for more information about side effects. | |||
What is SUTENT? SUTENT is a prescription medicine used to treat:
| |||
Before taking SUTENT tell your healthcare provider about all of your medical conditions, including if you:
Tell your healthcare provider about all the medicines you take, including prescription medicines and over-the-counter medicines, vitamins, and herbal supplements. Using SUTENT with certain other medicines can cause serious side effects. You may have an increased risk of severe jawbone problems (osteonecrosis) if you take SUTENT and a bisphosphonate medicine. Especially tell your healthcare provider if you are taking or have taken an osteoporosis medicine. Know the medicines you take. Keep a list of them to show your healthcare provider and pharmacist when you get a new medicine. | |||
How should I take SUTENT?
| |||
What are possible side effects of SUTENT? SUTENT may cause serious side effects, including:
| |||
|
| ||
| |||
|
| ||
Your healthcare provider may prescribe medicine for you to treat high blood pressure, if needed. | |||
| |||
|
| ||
| |||
|
| ||
| |||
|
| ||
Common side effects of SUTENT include: | |||
|
| ||
The medicine in SUTENT is yellow, and it may make your skin look yellow. Your skin and hair may get lighter in color. SUTENT may also cause other skin problems including: dryness, thickness or cracking of the skin. These are not all of the possible side effects of SUTENT. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. | |||
How do I store SUTENT?
| |||
General information about the safe and effective use of SUTENT. Medicines are sometimes prescribed for purposes other than those listed in a Medication Guide. Do not use SUTENT for a condition for which it was not prescribed. Do not give SUTENT to other people, even if they have the same symptoms that you have. It may harm them. You can ask your healthcare provider or pharmacist for information about SUTENT that is written for health professionals. | |||
What are the ingredients in SUTENT? Active ingredient: sunitinib malate Inactive ingredients: mannitol, croscarmellose sodium, povidone (K-25), and magnesium stearate. Orange gelatin capsule shells: titanium dioxide, and red iron oxide. Caramel gelatin capsule shells: titanium dioxide, red iron oxide, yellow iron oxide, and black iron oxide. Yellow gelatin capsule shells: titanium dioxide and yellow iron oxide. White printing ink: shellac, propylene glycol, sodium hydroxide, povidone, and titanium dioxide. Black printing ink: shellac, propylene glycol, potassium hydroxide and black iron oxide. LAB-0361-12.0 For more information go to www.SUTENT.com or call 1-877-5-SUTENT. |
Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.
*Contact Medical Information.9AM-5PM ET Monday to Friday; excluding holidays.
Pfizer Safety
To report an adverse event related to the Pfizer-BioNTech COVID-19 Vaccine, and you are not part of a clinical trial* for this product, click the link below to submit your information:
Pfizer Safety Reporting Site*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.
If you cannot use the above website, or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.
FDA Medwatch
You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or call (800) 822-7967.